Showing results (1451-1460 of 2,907) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|October 9, 2010
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoterS L Longo, C Griffith, A Glass, et al.Cancer Gene Therapy|June 19, 2010
Direct and indirect antitumor effects by human peripheral blood lymphocytes expressing both chimeric immune receptor and interleukin-2 in ovarian cancer xenograft modelJ M Lee, S H Yoon, H-S Kim, et al.Cancer Gene Therapy|May 15, 2010
Antigen quality determines the efficiency of antitumor immune responses generated in the absence of regulatory T cellsA-S Bergot, A Durgeau, B Levacher, et al.Cancer Gene Therapy|June 12, 2010
Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7Y-K Shi, Y P Yu, G C Tseng, et al.Cancer Gene Therapy|July 3, 2010
Recombinant adenovirus IL-24-Bax promotes apoptosis of hepatocellular carcinoma cells in vitro and in vivoJ Li, L Shi, X Zhang, et al.Cancer Gene Therapy|December 25, 2010
Direct gene transfer of adenoviral-mediated interferon α into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicityX-Q Zhang, Z Yang, W F BenedictCancer Gene Therapy|August 21, 2010
Multivalent immunity targeting tumor-associated antigens by intra-lymph node DNA-prime, peptide-boost vaccinationK A Smith, Z Qiu, R Wong, et al.Cancer Gene Therapy|August 21, 2010
Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63S-E Chow, J-S Wang, S-F Chuang, et al.Cancer Gene Therapy|August 21, 2010
Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in humanV Shahabi, M M Seavey, P C Maciag, et al.Pageof 291